Enhancement of the epitope vaccines from new gene wx2b4a of Toxoplasma gondii potency using pidotimod in mice
10.3760/cma.j.issn.0254-5101.2012.10.016
- VernacularTitle:匹多莫德增强弓形虫新基因wx2b4a表位疫苗免疫小鼠的保护研究
- Author:
Ronghua XIE
;
Jiubo FAN
- Publication Type:Journal Article
- Keywords:
Toxoplasma gondii;
Pidotimod;
Epitope vaccine;
Protective efficacy
- From:
Chinese Journal of Microbiology and Immunology
2012;(10):911-914
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of pidotimod to enhance the immune response and protective immunity induced by the epitope vaccines from new gene wx2b4a of Toxoplasma gondii in mice.Methods Mice were divided into four groups,each group was inoculated intramuscularly three times with pcDNA3-W2b4a,pcDNA3-W2b4a and pidotimod,pcDNA3,natural saline (NS),respectively.The induced immune responses were tested by ELISA detecting IgG,and flow cytometry sorting the subsets of T lymphocyte.All mice were challenged with highly virulent RH tachyzoites to observe the survival time.Results After the immunization,the level of IgG in sera of mice inoculated with wx2b4a and pidotimod,wx2b4a were significantly higher than those control group(all P＜0.05).CD4+ and CD8+T cell counts in immunized groups were higher than those control group(P＜0.05).After the immunization,CD4+T cell counts and CD4+/CD8+T cell proportion in wx2b4a and pidotimod groups were higher than those in wx2b4a group (all P＜0.05).After challenged with highly virulent tachyzoites,the mean survival time of wx2b4a and pidotimod groups was significantly longer than control group and wx2b4a group (all P＜0.05).Conclusion Pidotimod can increase protective immunity of epitope vaccines from new gene wx2b4a of Toxoplasma gondii in mice.
